dabigatran
Showing 476 - 495 of 495
Healthy Trial (BIBR 1048 MS Capsule A, BIBR 1048 MS Capsule B, BIBR 1048 MS Capsule C)
Completed
- Healthy
- BIBR 1048 MS Capsule A
- +5 more
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 953 ZW IV, BIBR 1048 MS tablet, BIBR 1048 MS oral solution)
Completed
- Healthy
- BIBR 953 ZW IV
- +3 more
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 1048 MS polymorph II, BIBR 1048 MS polymorph I)
Completed
- Healthy
- BIBR 1048 MS polymorph II
- BIBR 1048 MS polymorph I
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 1048 MS dose 1, BIBR 1048 MS dose 2, BIBR 1048 MS dose 3)
Completed
- Healthy
- BIBR 1048 MS dose 1
- +5 more
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 1048 low1, BIBR 1048 low2, BIBR 1048 medium)
Completed
- Healthy
- BIBR 1048 low1
- +4 more
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 1048 MS capsule formulation A, BIBR 1048 MS capsule formulation B, BIBR 1048 MS powder plus solution)
Completed
- Healthy
- BIBR 1048 MS capsule formulation A
- +3 more
- (no location specified)
Jun 20, 2014
Healthy Trial (BIBR 953 ZW Intravenously, BIBR 1048 Oral Solution)
Completed
- Healthy
- BIBR 953 ZW Intravenously
- BIBR 1048 Oral Solution
- (no location specified)
Jun 20, 2014
Cancer Thrombosis Trial in Burlington (Supervised aerobic exercise training)
Completed
- Cancer Thrombosis
- Supervised aerobic exercise training
-
Burlington, VermontFletcher Allen Healthcare
Dec 3, 2014
Venous Thromboembolism Trial in Worldwide (Enoxaparin, BIBR 1048)
Blood Coagulation Disorders Trial in Halifax (Dabigatran Etexilate 110 mg)
Completed
- Blood Coagulation Disorders
- Dabigatran Etexilate 110 mg
-
Halifax, Nova Scotia, CanadaCapital Health District Authority, Department of Medicine, Divis
Oct 31, 2012
Assays for and Reversal of New Anticoagulants
Completed
- Atrial Fibrillation
- +2 more
-
Perth, Western Australia, AustraliaRoyal Perth Hospital
Apr 30, 2013
Effect of Dabigatran on Coagulation parameters-an ex Vivo Study
Completed
- Effect of Dabigatran in Laboratory Coagulation Parameters
-
Frankfurt, GermanyJohann Wolfgang Goethe University Hospital
Jun 5, 2012
A Prospective Pharmacodynamic Study of Dabigatran
Completed
- Blood Coagulation Tests
- (no location specified)
Apr 27, 2012
Healthy Trial in Saint-Etienne (Dabigatran then dabigatran and clarithromycin, Clarithromycin and dabigatran then dabigatran)
Completed
- Healthy
- Dabigatran then dabigatran and clarithromycin
- Clarithromycin and dabigatran then dabigatran
-
Saint-Etienne, FranceService de Medecine et Therapeutique
Mar 21, 2012
Thrombosis, Anticoagulant-induced Bleeding, Anticoagulant Overdosage Trial in Barcelona (Rivaroxaban, Dabigatran)
Unknown status
- Thrombosis
- +3 more
- Rivaroxaban
- Dabigatran
-
Barcelona, SpainHospital Clinic, Fundació Clinic (FCRB)
Mar 9, 2012
Pradaxa (Dabigatran Etexilate 220 mg/q.d. in General Population
Completed
- Arthroplasty, Replacement
- Thromboembolism
-
Graz, Austria
- +111 more
Sep 13, 2012
Healthy Trial in New York (Warfarin)
Completed
- Healthy
-
New York, New YorkMount Sinai School of Medicine
Feb 6, 2013
Venous Thromboembolism Trial in Grenoble (Rivaroxaban, Dabigatran, Dabigatran; Rivaroxaban)
Completed
- Venous Thromboembolism
- Rivaroxaban, Dabigatran
- Dabigatran; Rivaroxaban
-
Grenoble, FranceClinical Research Centre, University Hospital Grenoble
Jun 30, 2011